Searched for
BIOCON LEADERSHIP TRANSITION
Industry expects policy continuity, faster execution under Shivakumar in KarnatakaExecutives from the technology, semiconductor and digital economy ecosystem said Karnataka’s long-standing strengths in talent, research an...- Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Biocon shares rise 1% after billionaire Kiran Mazumdar-Shaw names niece as successorBiocon's chairperson, Kiran Mazumdar-Shaw, has named her niece, Claire Mazumdar, as her successor, sparking a more than 1% jump in the comp...
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: ReportBiocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
- Biocon to make Biocon Biologics a wholly owned subsidiaryBiocon is set to fully integrate its biosimilar arm, Biocon Biologics. This move will make Biocon Biologics a wholly owned subsidiary. Bioc...
- Stocks to buy today: Morgan Stanley upgrades AB Capital; Motilal Oswal sees 20% upside in D-Mart post Q3 resultsMotilal Oswal Financial Services (MOSL) has reaffirmed its confidence in Avenue Supermarts, highlighting its leadership transition and long...
- Meet Kiran Mazumdar-Shaw's niece Claire: An MIT grad making Indian innovation shine with $1 billion market debutClaire Mazumdar, CEO of Bicara Therapeutics and niece of Kiran Mazumdar-Shaw, led her company to a successful Nasdaq debut, reaching a mark...
- Biocon Biologics completes integration of Viatris' biosimilar business in 120 countriesThe company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integrat...
- Success Stories of Indian Leaders: Inspiring Journeys of VisionariesThis article highlights the success stories of five remarkable Indian leaders who have achieved greatness and become a source of inspiratio...
- 'Biocon Biologics to integrate Viatris' US biosimilar business by Q2 end'Biocon Biologics plans to complete the integration of Viatris' biosimilar business in North America by the end of Q2FY24, which is ahead of...
- Inclusive, growth-oriented budget, says industry veteran Kiran Mazumdar-ShawInformation technology industry veteran T V Mohandas Pai called the budget "transformative" and the one that would ensure GDP growth stays ...
- How women empowerment has grown over the years in corporate India ?Women are the largest untapped reservoir of talent in the world. ~ Hillary Clinton It is undeniable that women empowerment in the corporate...
- KV Kamath steps down from Infosys, R Seshasayee appointed non-executive chairmanSeshasayee is currently a member of Infosys' nominations committee that also includes Lehman, Mazumdar-Shaw and Carol M Browner.
Load More
